Year: 2023

News

Press Release: FDA APPROVES FIRST-IN-CLASS EVKEEZA® (EVINACUMAB-DGNB) FOR YOUNG CHILDREN WITH ULTRA-RARE FORM OF HIGH CHOLESTEROL

TARRYTOWN, N.Y., March 22, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has extended the approval of Evkeeza® (evinacumab-dgnb) as an adjunct to other lipid-lowering therapies to…

Press Release: Ionis announces FDA acceptance of New Drug Application for eplontersen for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN)

CARLSBAD, Calif., March 7, 2023 /PRNewswire/ — Ionis Pharmaceuticals (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for eplontersen, an investigational antisense medicine…

Amgen Announces Cardiovascular Study to Evaluate Association between Lipoprotein(a) and Cardiovascular Risk in African Americans

Unique Community-Based Partnership With the Association of Black Cardiologists and Morehouse School of Medicine to Identify Study Sites and Participants Observational Study to Better Understand Associations Between Lp(a) Levels and Atherosclerotic Cardiovascular…

Michelle A. Albert, MD, MPH, Featured in TIME Magazine Special Issue on ‘The Future of Medicine’

Michelle A. Albert, MD, MPH, past president of the ABC and current president of the American Heart Association, is featured in several articles in TIME Magazine’s recent end of year…